Molecular Basis of Disease

On this page

Molecular Basis of Disease - DNA's Oopsie Daisies

  • Point Mutations (Single Base):
    • Missense: Altered amino acid. E.g., Sickle cell ($GAG \rightarrow GTG$).
    • Nonsense: Premature STOP codon. E.g., β-thalassemia.
    • Silent: No amino acid change.
  • Frameshift Mutations:
    • Insertion/deletion (not multiple of 3). Alters reading frame. E.g., Tay-Sachs.
  • Trinucleotide Repeats:
    • Expansion of 3-base repeats. E.g., Huntington's (CAG), Fragile X (CGG).
  • Chromosomal Alterations:
    • Deletions: E.g., Cri-du-chat (5p-).
    • Duplications.
    • Translocations: E.g., Philadelphia t(9;22) in CML.
  • Example: Cystic Fibrosis (CFTR mutations, e.g., ΔF508).

DNA mutation types: substitution, insertion, deletion

⭐ Sickle cell anemia results from a single GAG to GTG point mutation in the β-globin gene, leading to HbS.

Molecular Basis of Disease - Silent Gene Tweaks

  • Epigenetics: Gene expression changes, no DNA sequence alteration.
  • DNA Methylation:
    • Cytosine (CpG islands) methylation → gene silencing.
    • Example: Fragile X (FMR1 hypermethylation).
  • Histone Modifications:
    • Acetylation (HATs) → euchromatin → ↑ expression.
    • Deacetylation (HDACs) → heterochromatin → ↓ expression.
    • Methylation (HMTs) → context-dependent activation/repression. Epigenetic regulation of gene expression
  • Genomic Imprinting:
    • Parent-of-origin specific monoallelic expression.

    ⭐ Prader-Willi (paternal 15q11-13 deletion/silencing) vs. Angelman (maternal UBE3A/ 15q11-13 deletion/mutation).

  • X-Inactivation (Lyonization):
    • Random inactivation of one X in females (XX) via XIST lncRNA_.

Molecular Basis of Disease - Cellular Commotion Control

  • Key Signaling Pathways & Roles:
    • Receptor Tyrosine Kinases (RTKs): e.g., EGFR, VEGFR. Activate Ras-MAPK, PI3K/AKT/mTOR pathways.
    • G-Protein Coupled Receptors (GPCRs)
    • JAK-STAT Pathway
    • Control cell growth, differentiation, survival, apoptosis.
  • Dysregulation in Cancer:
    • Oncogenes: RAS, MYC (promote uncontrolled growth).
    • Tumor Suppressors: TP53 (guardian of genome), RB (cell cycle control); loss of function leads to unchecked proliferation.
  • Clinical Examples:
    • EGFR mutations: Lung adenocarcinoma.
    • HER2/neu amplification: Breast cancer.
    • RAS mutations: Pancreatic, colorectal cancers.

RTK-MAPK signaling pathway

⭐ The Philadelphia chromosome t(9;22) creates the BCR-ABL fusion gene, a constitutively active tyrosine kinase driving Chronic Myeloid Leukemia (CML).

Molecular Basis of Disease - Disease Detective Tools

  • PCR (Polymerase Chain Reaction): Amplifies DNA/RNA.
    • RT-PCR: RNA detection (e.g., viral infections).
    • qPCR: Quantifies nucleic acids (e.g., viral load, gene expression). PCR principle: denaturation, annealing, extension
  • FISH (Fluorescence In Situ Hybridization): Detects gene presence/location in cells.
    • Applications: Aneuploidy, HER2 amplification, BCR-ABL translocation, genetic disorders.

    ⭐ FISH can detect HER2/neu gene amplification in breast cancer, guiding targeted therapy with Trastuzumab.

  • Microarrays: Profile expression of thousands of genes.
    • Applications: Cancer gene expression profiling, disease signatures.
  • NGS (Next-Generation Sequencing): High-throughput DNA/RNA sequencing.
    • Applications: Diagnosing genetic disorders (e.g., CF), cancer mutations, minimal residual disease.
  • CRISPR-Cas9: Precise genome editing.
    • Applications: Research, potential gene therapy (e.g., thalassemias).

High‑Yield Points - ⚡ Biggest Takeaways

  • Single gene disorders follow Mendelian inheritance patterns: autosomal dominant/recessive, X-linked.
  • Trinucleotide repeat disorders (e.g., Huntington's) often show anticipation.
  • Mitochondrial DNA disorders exhibit maternal inheritance and heteroplasmy.
  • Genomic imprinting involves parent-of-origin specific gene expression (e.g., Prader-Willi/Angelman).
  • Epigenetic modifications (e.g., methylation) alter gene expression without DNA sequence changes.
  • Cancer involves activated oncogenes (e.g., RAS) and inactivated tumor suppressor genes (e.g., TP53).
  • Apoptosis is programmed cell death mediated by caspases via intrinsic or extrinsic pathways.
Rezzy AI Tutor

Have doubts about this lesson?

Ask Rezzy, our AI tutor, to explain anything you didn't understand

Practice Questions: Molecular Basis of Disease

Test your understanding with these related questions

Sumoylation of histone proteins is associated with

1 of 5

Flashcards: Molecular Basis of Disease

1/10

PAGE (DNA electrophoresis) will show a _____ pattern in Apoptosis

TAP TO REVEAL ANSWER

PAGE (DNA electrophoresis) will show a _____ pattern in Apoptosis

step-ladder

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start For Free